| Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors H Han, Q Ma, C Li, R Liu, L Zhao, W Wang, P Zhang, X Liu, G Gao, F Liu, ... Emerging microbes & infections 9 (1), 1123-1130, 2020 | 1103 | 2020 |
| Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA J Lucifora, Y Xia, F Reisinger, K Zhang, D Stadler, X Cheng, MF Sprinzl, ... Science 343 (6176), 1221-1228, 2014 | 1028 | 2014 |
| Interferon-γ and tumor necrosis factor-α produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis Y Xia, D Stadler, J Lucifora, F Reisinger, D Webb, M Hösel, T Michler, ... Gastroenterology 150 (1), 194-205, 2016 | 337 | 2016 |
| Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages X Cheng, Y Xia, E Serti, PD Block, M Chung, K Chayama, B Rehermann, ... Hepatology 66 (6), 1779-1793, 2017 | 159 | 2017 |
| Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions Y Xia, A Carpentier, X Cheng, PD Block, Y Zhao, Z Zhang, U Protzer, ... Journal of hepatology 66 (3), 494-503, 2017 | 122 | 2017 |
| Control of hepatitis B virus by cytokines Y Xia, U Protzer Viruses 9 (1), 18, 2017 | 121 | 2017 |
| Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential Y Xia, H Guo Antiviral research 180, 104824, 2020 | 120 | 2020 |
| Development of direct-acting antiviral and host-targeting agents for treatment of hepatitis B virus infection Y Xia, TJ Liang Gastroenterology 156 (2), 311-324, 2019 | 103 | 2019 |
| Hepatic differentiation of human pluripotent stem cells in miniaturized format suitable for high-throughput screen A Carpentier, I Nimgaonkar, V Chu, Y Xia, Z Hu, TJ Liang Stem cell research 16 (3), 640-650, 2016 | 92 | 2016 |
| Response to Comment on “Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA” Y Xia, J Lucifora, F Reisinger, M Heikenwalder, U Protzer Science 344 (6189), 1237-1237, 2014 | 66 | 2014 |
| Clinical characteristics of COVID‐19 patients with hepatitis B virus infection—a retrospective study R Liu, L Zhao, X Cheng, H Han, C Li, D Li, A Liu, G Gao, F Zhou, F Liu, ... Liver International 41 (4), 720-730, 2021 | 62 | 2021 |
| Breastfeeding risk from detectable severe acute respiratory syndrome coronavirus 2 in breastmilk C Zhu, W Liu, H Su, S Li, MA Shereen, Z Lv, Z Niu, D Li, F Liu, Z Luo, ... Journal of Infection 81 (3), 452-482, 2020 | 61 | 2020 |
| Hepatitis B virus deregulates the cell cycle to promote viral replication and a premalignant phenotype Y Xia, X Cheng, Y Li, K Valdez, W Chen, TJ Liang Journal of virology 92 (19), 10.1128/jvi. 00722-18, 2018 | 60 | 2018 |
| Insights into hepatitis B virus DNA integration-55 years after virus discovery K Zhao, A Liu, Y Xia The Innovation 1 (2), 2020 | 51 | 2020 |
| Descriptive, retrospective study of the clinical characteristics of asymptomatic COVID-19 patients H Han, Z Xu, X Cheng, Y Zhong, L Yuan, F Wang, Y Li, F Liu, Y Jiang, ... MSphere 5 (5), 10.1128/msphere. 00922-20, 2020 | 49 | 2020 |
| Interferon‐induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20 D Stadler, M Kächele, AN Jones, J Hess, C Urban, J Schneider, Y Xia, ... EMBO reports 22 (6), e49568, 2021 | 48 | 2021 |
| Hepatitis B surface antigen activates unfolded protein response in forming ground glass hepatocytes of chronic hepatitis B Y Li, Y Xia, X Cheng, DE Kleiner, SM Hewitt, J Sproch, T Li, H Zhuang, ... Viruses 11 (4), 386, 2019 | 46 | 2019 |
| Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection X Cheng, T Uchida, Y Xia, R Umarova, CJ Liu, PJ Chen, A Gaggar, V Suri, ... The Journal of Clinical Investigation 130 (6), 3205-3220, 2020 | 45 | 2020 |
| Analyses of HBV cccDNA quantification and modification Y Xia, D Stadler, C Ko, U Protzer Hepatitis B virus: methods and protocols, 59-72, 2017 | 45 | 2017 |
| 60 SVR12 rates and safety of triple therapy including telaprevir or boceprevir in 221 cirrhotic non responders treated in the French Early Access Program (ANRS CO20-CUPIC) H Fontaine, C Hezode, C Dorival, D Larrey, F Zoulim, V De Ledinghen, ... Journal of Hepatology, S27, 2013 | 45 | 2013 |
